XM does not provide services to residents of the United States of America.
C
C

Centamin

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

BMW, Life Science REIT, SGL Carbon

EUROPE RESEARCH ROUNDUP-BMW, Life Science REIT, SGL Carbon March 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including BMW, Life Science REIT and SGL Carbon on Wednesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Morgan Stanley raises to overweight from equal-weight * BMW BMWG.DE : Jefferies cuts to hold from buy * Credit Agricole SA CAGR.PA : Deutsche Bank raises to buy from hold * Life Science REIT Plc LABS.L : Jefferies cuts to hold from buy
A
B
B
B
B
C
C
C
D
E
E
E
F
H
H
L
N
O
S
A

Aker BP, Ascential, Var Energi

EUROPE RESEARCH ROUNDUP-Aker BP, Ascential, Var Energi March 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Aker BP ASA, Ascential and Var Energi ASA, on Friday. HIGHLIGHTS * Aker BP ASA AKRBP.OL : JP Morgan cuts to neutral from overweight * Aroundtown AT1.DE : Deutsche Bank cuts to sell from hold * Ascential Plc ASCL.L : HSBC cuts to hold from buy * Centamin Plc CEY.L : Liberum cuts to hold from buy * Var Energi ASA VAR.OL : J
A
B
B
B
C
E
E
E
E
G
H
I
K
L
M
N
R
U
W
A
A
A
B
E
P
R
R

Centamin Keeps 2024 Outlook Unchanged

BRIEF-Centamin Keeps 2024 Outlook Unchanged March 21 (Reuters) - Centamin PLC CEY.L : FULL YEAR 2023 RESULTS 2024 OUTLOOK GUIDANCE UNCHANGED DESPITE ONGOING LOCAL INFLATIONARY PRESSURES, WE REDUCED FY AISC BY $194/OZ VERSUS 2022, BEATING LOWER END OF OUR GUIDANCE RANGE SUKARI REPOSITIONED TOWARDS CONSISTENTLY DELIVERING 500,000 OUNCES PER ANNUM OVER LONG-TERM LOOKING AHEAD TO 2024, GRID CONNECTION PROJECT WILL CONTINUE OUR RECENT SUCCESS IN TAKING COSTS OUT OF BUSINESS FINAL DIVIDEND OF 2.0 US C
C

UK Stocks-Factors to watch on March 21

UK Stocks-Factors to watch on March 21 March 21 - Britain's FTSE 100 .FTSE index is seen opening higher on Thursday, with futures FFIc1 up 0.8%. * BARCLAYS: Barclays BARC.L is preparing to axe hundreds of jobs across its investment bank as it runs the rule over under-performers in the division, two sources familiar with the matter told Reuters. * SHELL: Shell SHEL.L said it had sold its 50% stake in SouthCoast Wind Energy, established to develop wind projects off the coast of Massachusetts, to i
B
B
B
C
E
G
H
L
N
P
S
D
U

Andritz, Buzzi Unicem, Vetoquinol

EUROPE RESEARCH ROUNDUP-Andritz, Buzzi Unicem, Vetoquinol Jan 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Andritz, Buzzi Unicem and Vetoquinol, on Thursday. HIGHLIGHTS * Andritz AG ANDR.VI : Exane BNP Paribas raises to neutral from underperform * Buzzi Unicem BZU.MI : Berenberg raises to buy from hold * Fdj FDJ.PA : Exane BNP Paribas raises to outperform from neutral * Fuller Smith & Turner Plc FSTA.L : Peel Hunt cuts to hol
A
A
A
B
B
B
B
B
B
C
C
C
C
C
C
D
E
H
I
P
S
S
S
A
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.